Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal AntibodiesNeurol 92:663-674, Johansen, A.,et al, 2019
Treatment of Acquired Myasthenia GravisNeurol 48 (Suppl 5) :S46-S51997., Massey,J.M., 1997